The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Republicans are already on shaky ground before the mid-term elections, and the loss of one of the most popular parts of the ACA might be a death knell.
In an attempt to shame drugmakers into keeping list prices down, a new federal dashboard highlights drugs with particularly rapid increases in unit costs.